BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7923986)

  • 1. Phosphate removal during dialysis--does the membrane matter?
    Ritz E
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S57-60. PubMed ID: 7923986
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of the new, steam-sterilized polysulfone high-flux dialyzer.
    Schaefer RM; Kulzer P; Gilge U; Schaefer L; Heidland A
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S21-5. PubMed ID: 7923978
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term experience with high-flux polysulfone in hemodialysis.
    Civati G; Teatini U; Guastoni C; Perego A; Perrino ML; Ballerini L; Minetti L
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S26-30. PubMed ID: 7923979
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience with polysulfone: 10 years.
    Vanholder R; Van Loo A; Ringoir S
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S13-20. PubMed ID: 7923977
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.
    Lonnemann G; Schindler R
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S37-43. PubMed ID: 7923982
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
    Klemm A; Sperschneider H; Winnefeld K; Günther K; Stein G
    Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodiafiltration using a polysulfone membrane, its ultrafiltration characteristics and biocompatibility].
    Iarmolinskiĭ IS; Stetsiuk EA; Iarmagomedov AA
    Urol Nefrol (Mosk); 1987; (2):45-9. PubMed ID: 3590419
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin clearance with high-flux dialysis membranes.
    Anandan JV; Touchette MA
    Int J Artif Organs; 1998 Mar; 21(3):131-3. PubMed ID: 9622110
    [No Abstract]   [Full Text] [Related]  

  • 10. All high-flux membranes are equal but some high-flux membranes are less equal than others.
    Vanholder R; Pedrini LA
    Nephrol Dial Transplant; 2008 May; 23(5):1481-3. PubMed ID: 18305315
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
    Kadiri S; Kehinde Z; Arije A; Salako BL
    Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
    Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
    Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodialysis using high flux membranes improves lipid profiles.
    Blankestijn PJ
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S48-51. PubMed ID: 7923984
    [No Abstract]   [Full Text] [Related]  

  • 14. Fresenius Polysulfone--the "gold standard" in dialysis. 10 Years of experience.
    Brachtendorf T; Nederlof B
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S3-12. PubMed ID: 7923980
    [No Abstract]   [Full Text] [Related]  

  • 15. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
    Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
    Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of a polyelectrolyte additive on the selective dialysis membrane permeability for low-molecular-weight proteins.
    Krieter DH; Morgenroth A; Barasinski A; Lemke HD; Schuster O; von Harten B; Wanner C
    Nephrol Dial Transplant; 2007 Feb; 22(2):491-9. PubMed ID: 17050637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers.
    Ouseph R; Hutchison CA; Ward RA
    Nephrol Dial Transplant; 2008 May; 23(5):1704-12. PubMed ID: 18156455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fresenius Polysulfone--membrane developments to meet clinical demands.
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S1-60. PubMed ID: 7923976
    [No Abstract]   [Full Text] [Related]  

  • 19. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
    Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S
    Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility of DIAPES.
    Bonomini M; Di Stante S; Sirolli V
    Contrib Nephrol; 2003; (138):117-25. PubMed ID: 12463154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.